Association between gout and all-cause as well as cardiovascular mortality: A systematic review

Current Rheumatology Reports

Volumn 14, Issue 2, 2012, Pages 195-203

  Lottmann, Kathrin ^a   Chen, Xiaoyu ^a   Schädlich, Peter K ^a  

^a IGES Institut GmbH   (Germany)

Author keywords

All cause mortality; Association; Cardiovascular mortality; Crystal arthritis; Gout; Mortality; Systematic review

Indexed keywords

ALLOPURINOL; COLCHICINE; PROBENECID;

AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; ETHNIC DIFFERENCE; GOUT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT CARE; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; GOUT; HUMANS; RISK FACTORS;

EID: 84862822542     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-011-0234-2     Document Type: Review

References (31)

1. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1301-11. (Pubitemid 44641591)
2. Doherty M. New insights into the epidemiology of gout. Rheumatology. 2009;48 Suppl 2:ii2-8.
3. Tausche AK, Jansen TL, Schröder HE, et al. Gout - current diagnosis and treatment. Dtsch Arztebl Int. 2009;106:549-55.
4. Gresser U. Diagnosis and therapy of gout. Dtsch Artzebl. 2003;100:2862-70.
5. Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout-a systematic review. Rheumatology. 2006;45:1422-31. (Pubitemid 44605481)
6. Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.
7. Mikuls TR, Saag KG. New insights into gout epidemiology. Curr Opin Rheumatol. 2006;18:199-203. (Pubitemid 43740396)
8. Annemans L, Spaepen E, Gaskin M, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67:960-6. (Pubitemid 351956658)
9. Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65:1312-24. (Pubitemid 44620440)
10. Rider TG, Jordan KM. The modern management of gout. Rheumatology. 2010;49:5-14.
11. Erratum in: Rheumatology 2010, 49:830.
12. Weselman KO, Agudelo CA. Is it gout? Tap the joint! J Med Assoc Ga. 2002;91:18-20.
13. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Atlanta, GA: Centers for Disease Control and Prevention. 2011 [updated 2011 Sep 23]. . Accessed Oct 2011.
14. World Health Organization: International Statistical Classification of Diseases and Related Health Problems 10th Revision, Version for 2010. Geneva: World Health Organisation. http://apps.who.int/ classifications/apps/icd/ icd10online/. Accessed Jun 2011.
15. Centre for Evidence Based Medicine. Levels of Evidence. Oxford: Centre for Evidence-based Medicine. 1998 [updated 2009 Mar]. http://www.cebm.net/index. aspx?o01025. Accessed Oct 2011.
16. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):1-173.
17. Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine: how to review and apply findings of healthcare rResearch. London: Royal Society of Medicine Press Ltd; 2003.
18. DAHTA@DIMDI.de: [Methodological requirements for preparing an HTA-report]. Cologne: German Institute for Medical Documentation and Information, n.a.
19. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:163-94.
20. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008;67:1310-6.
21. Abbott KC, Kimmel PL, Dharnidharka V, et al. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation. 2005;80:1383-91. (Pubitemid 41803617)
22. Cohen SD, Kimmel PL, Neff R, et al. Association of incident gout and mortality in dialysis patients. J Am Soc Nephrol. 2008;19:2204-10.
23. ••Thanassoulis G, Brophy JM, Richard H, Piloe L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med 2010; 170:1358-64. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause mortality.
24. Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med. 2008;168:1104-10. (Pubitemid 351749228)
25. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894-900. (Pubitemid 47300913)
26. ••Kuo CF, See LC, Luo SF, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology. 2010; 49:141-6. This paper was identified in the systematic literature search and used multivariate regression to analyze the association between gout and all-cause as well as cardiovascular mortality.
27. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41:237-42. (Pubitemid 18069583)
28. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54: 2688-96. (Pubitemid 44208638)
29. Nishioka K, Mikanagi K. A retrospective study on the cause of death, in Japan, of patients with gout. Ryumachi. 1981;21: 29-33. (Pubitemid 12108890)
30. Nishioka N, Mikanagi K. Clinical features of 4,000 gouty subjects in Japan. Adv Exp Med Biology. 1980;122A:47-54.
31. Wijands JMA, Boonen A, Arts ICW, et al. Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria. Curr Rheumatol Rep. 2011;13:167-74.